|
|||||
EfalizumabEfalizumab Article SummaryEfalizumab (trade Name Raptiva, Genentech, Merck Serono) Is A Medication Used To Treat Psoriasis. As Its Name Implies, It Is A Recombinant Humanized Monoclonal Antibody That Binds To Cd11a And Acts As An Immunosuppressant. It Is Administered Once Weekly By Subcutaneous Injection. it Acts To Inhibit White Blood Cell Migration Out Of Blood Vessels Into Tissues. this Monoclonal Antibody-related Article Is A Stub. You Can Help Wikipedia By Expanding It. v d ... Read the Full Efalizumab ArticleArticle May Include Instructions, Side Effects, Interactions, Etc. This article is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License) | http://en.wikipedia.org/wiki/Efalizumab Possible Dosages for this and Related Drugs:Note: May Include Dosages for Drugs similar to EfalizumabPowder for Reconstitution 125mg Vial 125mg/vial Related Drug Page(s): Related Search Results for EfalizumabWebmasters or Publishers: Link To This Drug ListingCopy and Paste the HTML Code Below to Create a Link to this Listing from any Web Page or Email.Graphical Link:
Graphical Link HTML Code: Text Link: Learn About Efalizumab Text Link HTML Code: Related: identify Efalizumab, Efalizumab list, Efalizumab industry, Efalizumab trials technical pharmacology, Efalizumab dose, Efalizumab almanac pill, meds pdr material national storage Efalizumab, book consultation research Efalizumab, Efalizumab posting consultation, Efalizumab approval consultation report medication clinical. Return to Top Start a New Discussion About this DrugThis information has been independently compiled and is for educational purposes only. It is not intended to be a substitute for professional medical advice. Please remember that the content within this community is totally compiled by users of this site. Our website displays many pages which do not contain any medical information regarding the drug name stated. These pages are only provided for the purpose of opening community discussions about that drug by our users. For more details please see the Disclaimer. This data is Copyright © 2005-2009 PrescriptionDrug-Info.com and is protected under U.S. and International Copyright laws. All Rights Reserved. Drugs/Efalizumab.asp Last Updated June 27 2005 |
|||||